Association of ficolin-3 with severity and outcome of chronic heart failure

Zoltán Prohászka1, Lea Munthe-Fog, Thor Ueland

  • 1IIIrd Department of Internal Medicine, Semmelweis University, and Research Group of Inflammation Biology and Immunogenomics, Hungarian Academy of Sciences, Budapest, Hungary.

Plos One
|April 19, 2013
PubMed

Insights

Low levels of ficolin-3, a key complement pathway initiator, are linked to advanced heart failure and increased mortality risk. This finding highlights ficolin-3

Area of Science:

  • Immunology
  • Cardiology
  • Complement System

Background:

  • Complement activation plays a role in heart failure pathophysiology.
  • Initiating mechanisms of complement activation in heart failure remain unclear.
  • Mannose-binding lectin (MBL), ficolin-2, and ficolin-3 are key initiators of the lectin complement pathway.

Purpose of the Study:

  • To investigate the association of MBL, ficolin-2, and ficolin-3 with disease severity and outcome in chronic heart failure.
  • To determine if these lectin pathway initiators are related to clinical parameters and mortality in heart failure patients.

Main Methods:

  • Plasma concentrations of MBL, ficolin-2, and ficolin-3 were measured in two independent cohorts of heart failure patients and controls.
  • Disease severity (NYHA class) and clinical parameters (BNP) were assessed at baseline.
  • All-cause mortality was tracked over a 5-year follow-up period.
  • Univariate and multivariable Cox regression analyses were performed.

Main Results:

  • Low ficolin-3 levels, but not MBL or ficolin-2, were significantly associated with advanced heart failure (NYHA Class IV).
  • Decreased ficolin-3 inversely correlated with B-type natriuretic peptide (BNP) levels.
  • Low plasma ficolin-3 was a significant independent predictor of 5-year mortality.
  • Reduced ficolin-3 levels correlated with increased complement activation (C3a) and decreased complement factor C3.

Conclusions:

  • Low ficolin-3 levels are associated with advanced heart failure.
  • Findings from two independent cohorts consistently show that low ficolin-3 levels predict poor outcome in heart failure.
  • Decreased ficolin-3 is linked to heightened complement activation in the context of heart failure.
Abstract

Related Concept Videos

Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...